These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 733550)

  • 1. [Hemodynamic study of a new injectable anti-hypertensive: labetalol].
    Clementy J; Dallocchio M
    Nouv Presse Med; 1978 Dec; 7(43):3934. PubMed ID: 733550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophysiologic properties of intravenous labetalol in normotensive and hypertensive patients].
    Clémenty J; Dallocchio M; Bricaud H
    Arch Mal Coeur Vaiss; 1981 Jan; 74(1):65-71. PubMed ID: 6781440
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Eur J Clin Pharmacol; 1980 Jan; 17(1):5-11. PubMed ID: 7371699
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of intravenous labetalol on hemodynamics and myocardial metabolism in coronary insufficiency].
    Lardoux H; Ourbak P; Pornin M; Duong TC; Chouty F; Maurice P
    Therapie; 1983; 38(2):149-54. PubMed ID: 6636022
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of labetalol on the response of arterial blood pressure to exercise in hypertensive patients].
    Wajngarten M; Antunes JE; Pereyra PL; Godoy M; Dauar D; Martinelli Filho M; Pereira Barretto AC; Pileggi F
    Arq Bras Cardiol; 1983 Jan; 40(1):65-7. PubMed ID: 6615264
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute hemodynamic effects of labetalol in severe hypertension.
    Omvik P; Lund-Johansen P
    J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled hypotension with labetalol in lengthy otologic microsurgery (hemodynamic study)].
    Bertrand D; Bollaert PE; Laxenaire MC; Wayoff M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1984 Nov; 33(9):461-71. PubMed ID: 6527119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravenous labetalol in normotensive coronary patients. Effects on hemodynamics and myocardial metabolism].
    Ourbak P; Lardoux H; Pornin M; Bouziri S; Allal J; Duong TC; Sellier P; Maurice M
    Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1089-96. PubMed ID: 3929738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I.V. Labetalol during coronary artery surgery.
    Joucken K
    Acta Anaesthesiol Belg; 1983; 34(1):15-26. PubMed ID: 6845955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
    Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
    Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Labetalol: a new hypotensive agent in surgery of the middle ear. Peroperative hemodynamic study].
    Bertrand D; Guyon D; Maday T; Laxenaire MC
    Ann Fr Anesth Reanim; 1982; 1(4):387-92. PubMed ID: 7171135
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of labetalol in healthy volunteers.
    Allonen H; Kanto J; Pakkanen A; Wendelin H
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):517-9. PubMed ID: 7174154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of intravenous labetalol in essential hypertension.
    Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
    Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effects of labetalol on the humeral artery of the hypertensive patient. A double-blind study versus placebo].
    Pithois-Merli I; Cournot AX; Georges DR; Pappo M; Safar ME
    Ann Cardiol Angeiol (Paris); 1987; 36(7):371-4. PubMed ID: 3662385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.
    Koch G
    Br Heart J; 1979 Feb; 41(2):192-8. PubMed ID: 106867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.